Stay updated on Elranatamab in Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab in Refractory Multiple Myeloma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    An official new revision entry v3.5.4 was added to the study record history. The previous revision v3.5.3 was removed, indicating an update to the record.
    Difference
    0.1%
    Check dated 2026-05-15T02:27:23.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page’s revision line has been updated from v3.5.2 to v3.5.3. This reflects a new release version in the site history without altering study content.
    Difference
    0.1%
    Check dated 2026-04-30T18:53:00.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added to the history, and Revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:08:04.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the Record History and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:12:51.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history, indicating a site version update.
    Difference
    0.1%
    Check dated 2026-03-11T15:53:54.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page shows an added Revision: v3.4.2 and the removal of prior notices including the lapse-in-funding message and the v3.4.1 revision notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:11:50.000Z thumbnail image

Stay in the know with updates to Elranatamab in Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.